Colgate-Palmolive (NYSE:CL – Get Rating) insider Sally Massey sold 656 shares of the company in a trade that took place on Tuesday, September 13. The shares were sold at an average price of $77.58, for a total value of $50,892.48. Following the completion of the transaction, the insider now owns 7,913 shares of the company, valued at approximately $613,890.54. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
Colgate-Palmolive Price Performance
CL traded down $0.83 during Thursday’s trading, hitting $75.23. The stock recorded a trading volume of 4,294,222 shares, compared to an average volume of 5,033,649 shares. The stock has a market capitalization of $62.75 billion, a PE ratio of 32.37, a PEG ratio of 5.40 and a beta of 0.48. The company has a debt ratio of 14.26, a quick ratio of 0.72 and a current ratio of 1.17. Colgate-Palmolive has a one-year low of $72.20 and a one-year high of $85.61. The company has a 50-day moving average of $79.24 and a 200-day moving average of $78.11.
Colgate-Palmolive (NYSE:CL – Get Rating) last reported results on Friday, July 29. The company reported EPS of $0.72 for the quarter, beating consensus analyst estimates of $0.71 by $0.01. The company posted revenue of $4.48 billion for the quarter, versus $4.35 billion expected by analysts. Colgate-Palmolive achieved a return on equity of 315.10% and a net margin of 10.98%. The company’s revenue increased 5.3% year over year. In the same quarter of the previous year, the company had earned earnings per share of $0.80. As a group, equity research analysts expect Colgate-Palmolive to post EPS of 3.03 for the current fiscal year.
Colgate-Palmolive announces dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, November 15. Shareholders of record on Friday, October 21 will receive a dividend of $0.47 per share. The ex-dividend date is Thursday, October 20. This represents a dividend of $1.88 on an annualized basis and a dividend yield of 2.50%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 81.39%.
Analyst upgrades and downgrades
Several equity analysts have recently commented on CL shares. Wells Fargo & Company raised Colgate-Palmolive to an “equal weight” rating in a Tuesday, Aug. 9 research note. StockNews.com upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating in a Tuesday, Aug. 2 research report. Barclays raised its price target on Colgate-Palmolive from $71.00 to $74.00 and gave the stock an “equal weight” rating in a Tuesday, Aug. 2 research report. JPMorgan Chase & Co. lowered its price target on Colgate-Palmolive from $79.00 to $78.00 in a Thursday, July 21 research report. Finally, UBS Group raised its price target on Colgate-Palmolive from $88.00 to $90.00 and gave the stock a “buy” rating in a Monday, Aug. 1 research report. Twelve equity research analysts have rated the stock with a hold rating and four have assigned the stock a buy rating. According to data from MarketBeat.com, Colgate-Palmolive has an average rating of “Hold” and a consensus target price of $84.57.
Institutional entries and exits
A number of institutional investors and hedge funds have recently shifted their CL holdings. TCI Wealth Advisors Inc. increased its stake in Colgate-Palmolive shares by 76.0% in the second quarter. TCI Wealth Advisors Inc. now owns 315 shares of the company worth $25,000 after buying 136 more shares in the last quarter. Better Money Decisions LLC bought a new stake in Colgate-Palmolive stock in the second quarter worth about $25,000. Core Alternative Capital increased its stake in Colgate-Palmolive shares by 924.3% in the first quarter. Core Alternative Capital now owns 379 shares of the company worth $29,000 after buying 342 additional shares in the last quarter. Carl Stuart Investment Advisor Inc. bought a new equity stake in Colgate-Palmolive in the first quarter worth about $30,000. Finally, Investors Asset Management of Georgia Inc. GA ADV bought a new equity stake in Colgate-Palmolive in the second quarter worth about $35,000. 78.62% of the shares are held by institutional investors.
About Colgate Palmolive
(Get a rating)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The Company operates through two segments, Oral, Personal and Home Care; and animal nutrition. The Oral, Personal and Home Care segment offers toothpastes, toothbrushes, mouthwashes, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin care products, dishwashing detergents, fabric conditioners, household cleaners and other related items.
This instant alert was powered by MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]
Before you consider Colgate-Palmolive, you’ll want to hear this.
MarketBeat tracks daily the highest rated and most successful research analysts on Wall Street and the stocks they recommend to their clients. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market takes off…and Colgate-Palmolive wasn’t on the list.
While Colgate-Palmolive currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
See the five actions here